120 related articles for article (PubMed ID: 8992968)
21. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
[TBL] [Abstract][Full Text] [Related]
22. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
[TBL] [Abstract][Full Text] [Related]
23. Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.
Falkenburg JH; Goselink HM; van der Harst D; van Luxemburg-Heijs SA; Kooy-Winkelaar YM; Faber LM; de Kroon J; Brand A; Fibbe WE; Willemze R
J Exp Med; 1991 Jul; 174(1):27-33. PubMed ID: 2056279
[TBL] [Abstract][Full Text] [Related]
24. [Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation].
Hudecek M; Bartsch K; Tschiedel S; Niederwieser D
Dtsch Med Wochenschr; 2008 Jul; 133(28-29):1511-6. PubMed ID: 18597211
[TBL] [Abstract][Full Text] [Related]
25. Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation.
Ibisch C; Gallot G; Vivien R; Diez E; Jotereau F; Garand R; Vié H
Bone Marrow Transplant; 1999 Jun; 23(11):1153-9. PubMed ID: 10382955
[TBL] [Abstract][Full Text] [Related]
26. Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.
Kloosterboer FM; van Luxemburg-Heijs SA; van Soest RA; Barbui AM; van Egmond HM; Strijbosch MP; Kester MG; Marijt WA; Goulmy E; Willemze R; Falkenburg JH
Leukemia; 2004 Apr; 18(4):798-808. PubMed ID: 14973499
[TBL] [Abstract][Full Text] [Related]
27. Generation of HLA-A2 subtype specific cytotoxic T lymphocytes from cord blood used for cord blood stem cell transplantation.
Yazaki M; Takahashi T; Ito Y; Ito T; Mori C; Wada Y
Bone Marrow Transplant; 2000 Aug; 26(4):451-3. PubMed ID: 10982294
[TBL] [Abstract][Full Text] [Related]
28. Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma.
Kobayashi J; Hirohashi Y; Torigoe T; Michifuri Y; Yamamoto T; Tamura Y; Kamiguchi K; Miyazaki A; Yamaguchi A; Hariu H; Hiratsuka H; Sato N
Hum Immunol; 2009 Feb; 70(2):89-95. PubMed ID: 19124056
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.
Warren EH; Greenberg PD; Riddell SR
Blood; 1998 Mar; 91(6):2197-207. PubMed ID: 9490709
[TBL] [Abstract][Full Text] [Related]
30. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403.
Terakura S; Murata M; Warren EH; Sette A; Sidney J; Naoe T; Riddell SR
Transplantation; 2007 May; 83(9):1242-8. PubMed ID: 17496542
[TBL] [Abstract][Full Text] [Related]
31. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
[TBL] [Abstract][Full Text] [Related]
32. Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.
Stronen E; Abrahamsen IW; Gaudernack G; Wälchli S; Munthe E; Buus S; Johansen FE; Lund-Johansen F; Olweus J
Scand J Immunol; 2009 Apr; 69(4):319-28. PubMed ID: 19284496
[TBL] [Abstract][Full Text] [Related]
33. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
[TBL] [Abstract][Full Text] [Related]
34. Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigens.
de Rijke B; van Horssen-Zoetbrood A; Veenbergen S; Fredrix H; de Witte T; van de Wiel-van Kemenade E; Dolstra H
J Immunol Methods; 2008 Jan; 329(1-2):125-37. PubMed ID: 17996247
[TBL] [Abstract][Full Text] [Related]
35. Generation of cytotoxic T lymphocytes specific for B-cell acute lymphoblastic leukemia family-shared peptides derived from immunoglobulin heavy chain framework region.
Liu Y; Zhu P; Hu YM
Chin Med J (Engl); 2007 Apr; 120(8):652-7. PubMed ID: 17517179
[TBL] [Abstract][Full Text] [Related]
36. Identification of the HLA-Cw*0702-restricted tumor-associated antigen recognized by a CTL clone from a lung cancer patient.
Nagata Y; Hanagiri T; Takenoyama M; Fukuyama T; Mizukami M; So T; Ichiki Y; Sugaya M; Sugio K; Yasumoto K
Clin Cancer Res; 2005 Jul; 11(14):5265-72. PubMed ID: 16033845
[TBL] [Abstract][Full Text] [Related]
37. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs.
Gomi S; Nakao M; Niiya F; Imamura Y; Kawano K; Nishizaka S; Hayashi A; Sobao Y; Oizumi K; Itoh K
J Immunol; 1999 Nov; 163(9):4994-5004. PubMed ID: 10528204
[TBL] [Abstract][Full Text] [Related]
38. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
39. Potential role of a mismatched HLA-specific CTL clone developed pre-transplant in graft rejection following cord blood transplantation.
Narimatsu H; Murata M; Terakura S; Sugimoto K; Naoe T
Biol Blood Marrow Transplant; 2008 Apr; 14(4):397-402. PubMed ID: 18342781
[TBL] [Abstract][Full Text] [Related]
40. The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206.
Torikai H; Akatsuka Y; Miyauchi H; Terakura S; Onizuka M; Tsujimura K; Miyamura K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
Bone Marrow Transplant; 2007 Jul; 40(2):165-74. PubMed ID: 17530010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
